vs
REGIS CORP（RGS）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是REGIS CORP的1.2倍（$69.8M vs $57.1M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 0.8%，领先383.2%），REGIS CORP同比增速更快（22.3% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 7.8%）
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
RGS vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.2倍
$57.1M
营收增速更快
RGS
高出1.1%
21.2%
净利率更高
RIGL
高出383.2%
0.8%
两年增速更快
RIGL
近两年复合增速
7.8%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.1M | $69.8M |
| 净利润 | $456.0K | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 10.8% | 33.2% |
| 净利率 | 0.8% | 384.0% |
| 营收同比 | 22.3% | 21.2% |
| 净利润同比 | -94.0% | 1769.2% |
| 每股收益（稀释后） | $0.16 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RGSRIGL
| Q4 25 | $57.1M | $69.8M | ||
| Q3 25 | $59.0M | $69.5M | ||
| Q2 25 | $60.4M | $101.7M | ||
| Q1 25 | $57.0M | $53.3M | ||
| Q4 24 | $46.7M | $57.6M | ||
| Q3 24 | $46.1M | $55.3M | ||
| Q2 24 | $49.4M | $36.8M | ||
| Q1 24 | $49.2M | $29.5M |
净利润RGSRIGL
| Q4 25 | $456.0K | $268.1M | ||
| Q3 25 | $1.4M | $27.9M | ||
| Q2 25 | $116.5M | $59.6M | ||
| Q1 25 | $250.0K | $11.4M | ||
| Q4 24 | $7.6M | $14.3M | ||
| Q3 24 | $-853.0K | $12.4M | ||
| Q2 24 | $91.2M | $-1.0M | ||
| Q1 24 | $-2.3M | $-8.2M |
毛利率RGSRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率RGSRIGL
| Q4 25 | 10.8% | 33.2% | ||
| Q3 25 | 10.0% | 40.9% | ||
| Q2 25 | 12.1% | 60.1% | ||
| Q1 25 | 8.8% | 23.9% | ||
| Q4 24 | 11.8% | 28.9% | ||
| Q3 24 | 4.6% | 25.4% | ||
| Q2 24 | — | 1.2% | ||
| Q1 24 | 8.3% | -23.6% |
净利率RGSRIGL
| Q4 25 | 0.8% | 384.0% | ||
| Q3 25 | 2.3% | 40.2% | ||
| Q2 25 | 192.9% | 58.6% | ||
| Q1 25 | 0.4% | 21.5% | ||
| Q4 24 | 16.4% | 24.9% | ||
| Q3 24 | -1.9% | 22.5% | ||
| Q2 24 | 184.7% | -2.8% | ||
| Q1 24 | -4.7% | -27.9% |
每股收益（稀释后）RGSRIGL
| Q4 25 | $0.16 | $14.11 | ||
| Q3 25 | $0.49 | $1.46 | ||
| Q2 25 | $43.67 | $3.28 | ||
| Q1 25 | $0.08 | $0.63 | ||
| Q4 24 | $2.71 | $0.82 | ||
| Q3 24 | $-0.36 | $0.70 | ||
| Q2 24 | $38.40 | $-0.06 | ||
| Q1 24 | $-1.00 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.4M | $155.0M |
| 总债务越低越好 | $113.3M | $52.5M |
| 股东权益账面价值 | $188.7M | $391.5M |
| 总资产 | $588.3M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.60× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资RGSRIGL
| Q4 25 | $18.4M | $155.0M | ||
| Q3 25 | $16.6M | $137.1M | ||
| Q2 25 | $17.0M | $108.4M | ||
| Q1 25 | $13.3M | $77.1M | ||
| Q4 24 | $10.2M | $77.3M | ||
| Q3 24 | $6.3M | $61.1M | ||
| Q2 24 | $10.1M | $49.1M | ||
| Q1 24 | $5.9M | $49.5M |
总债务RGSRIGL
| Q4 25 | $113.3M | $52.5M | ||
| Q3 25 | $111.3M | $60.0M | ||
| Q2 25 | $110.8M | $60.0M | ||
| Q1 25 | $112.0M | $60.0M | ||
| Q4 24 | $111.5M | $60.0M | ||
| Q3 24 | $95.2M | $60.0M | ||
| Q2 24 | $99.5M | $60.0M | ||
| Q1 24 | $179.7M | $60.0M |
股东权益RGSRIGL
| Q4 25 | $188.7M | $391.5M | ||
| Q3 25 | $187.6M | $117.6M | ||
| Q2 25 | $185.6M | $81.9M | ||
| Q1 25 | $68.6M | $18.6M | ||
| Q4 24 | $66.7M | $3.3M | ||
| Q3 24 | $56.4M | $-14.6M | ||
| Q2 24 | $56.8M | $-29.9M | ||
| Q1 24 | $-35.8M | $-31.7M |
总资产RGSRIGL
| Q4 25 | $588.3M | $513.6M | ||
| Q3 25 | $592.1M | $242.5M | ||
| Q2 25 | $599.0M | $206.7M | ||
| Q1 25 | $511.2M | $176.0M | ||
| Q4 24 | $530.1M | $164.0M | ||
| Q3 24 | $508.9M | $139.4M | ||
| Q2 24 | $530.5M | $128.4M | ||
| Q1 24 | $543.7M | $126.5M |
负债/权益比RGSRIGL
| Q4 25 | 0.60× | 0.13× | ||
| Q3 25 | 0.59× | 0.51× | ||
| Q2 25 | 0.60× | 0.73× | ||
| Q1 25 | 1.63× | 3.23× | ||
| Q4 24 | 1.67× | 18.25× | ||
| Q3 24 | 1.69× | — | ||
| Q2 24 | 1.75× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.7M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $891.0K | — |
| 自由现金流率自由现金流/营收 | 1.6% | — |
| 资本支出强度资本支出/营收 | 1.4% | — |
| 现金转化率经营现金流/净利润 | 3.65× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $14.9M | — |
8季度趋势，按日历期对齐
经营现金流RGSRIGL
| Q4 25 | $1.7M | $22.0M | ||
| Q3 25 | $2.3M | $24.0M | ||
| Q2 25 | $6.8M | $30.5M | ||
| Q1 25 | $6.2M | $-893.0K | ||
| Q4 24 | $2.1M | $14.5M | ||
| Q3 24 | $-1.3M | $21.7M | ||
| Q2 24 | $5.1M | $302.0K | ||
| Q1 24 | $-277.0K | $-5.0M |
自由现金流RGSRIGL
| Q4 25 | $891.0K | — | ||
| Q3 25 | $1.9M | — | ||
| Q2 25 | $6.2M | — | ||
| Q1 25 | $5.9M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $-1.4M | — | ||
| Q2 24 | $5.1M | — | ||
| Q1 24 | $-326.0K | — |
自由现金流率RGSRIGL
| Q4 25 | 1.6% | — | ||
| Q3 25 | 3.2% | — | ||
| Q2 25 | 10.3% | — | ||
| Q1 25 | 10.3% | — | ||
| Q4 24 | 3.6% | — | ||
| Q3 24 | -3.0% | — | ||
| Q2 24 | 10.3% | — | ||
| Q1 24 | -0.7% | — |
资本支出强度RGSRIGL
| Q4 25 | 1.4% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.1% | — |
现金转化率RGSRIGL
| Q4 25 | 3.65× | 0.08× | ||
| Q3 25 | 1.68× | 0.86× | ||
| Q2 25 | 0.06× | 0.51× | ||
| Q1 25 | 24.80× | -0.08× | ||
| Q4 24 | 0.28× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 0.06× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
RIGL
暂无分部数据
